SCHEMBL8285685

SCHEMBL8285685

CCOC(=O)c1ccc2c(c1)nc(N)n2Cc1ccc(F)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.52
KDM4E B2RXH2 3/20 0.52
HPGD P15428 2/20 0.52
LMNA P02545 1/20 0.52
MAPT P10636 7/20 0.51
PKM P14618 1/20 0.50
PPARG P37231 1/20 0.49
NPC1 O15118 2/20 0.49
RAB9A P51151 2/20 0.49
MEN1 O00255 2/20 0.49
KMT2A Q03164 2/20 0.49
AGTR1 P30556 1/20 0.48
AGTR2 P50052 1/20 0.48
POLB P06746 3/20 0.48
HTT P42858 3/20 0.48
NLRP3 Q96P20 1/20 0.48
SIRT2 Q8IXJ6 1/20 0.47
SIRT1 Q96EB6 1/20 0.47
RECQL P46063 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8285684 0.91 MAPT (0.48) ALDH1A1KDM4EHPGDLMNAMAPT
SCHEMBL30586473 0.86 ALDH1A1 (0.50) ALDH1A1KDM4EHPGDMAPTNPC1
SCHEMBL25297307 0.86 ALDH1A1 (0.50) ALDH1A1KDM4EHPGDMAPTNPC1
SCHEMBL5466787 0.84 AGTR1 (0.56) ALDH1A1KDM4EPPARGKMT2AAGTR1
SCHEMBL22382307 0.84 KMT2A (0.63) ALDH1A1KDM4EHPGDLMNAMAPT
SCHEMBL25828145 0.82 NPC1 (0.47) ALDH1A1KDM4EHPGDLMNAMAPT
SCHEMBL8284622 0.81 SIRT2 (0.50) ALDH1A1KDM4EHPGDMAPTNPC1
SCHEMBL8284696 0.81 SIRT2 (0.48) ALDH1A1KDM4EHPGDMAPTNPC1
SCHEMBL12226886 0.79 MAPT (0.49) ALDH1A1KDM4EHPGDMAPTNPC1
SCHEMBL22382310 0.79 PTGER4 (0.63) ALDH1A1KDM4EMAPTNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8044073-B2 Aminobenzimidazoles and benzimidazoles as inhibitors of respiratory syncytial virus replication TIBOTEC PHARMACEUTICALS (IE) 2011-10-25 US disclosed
US-8044073-B2 Aminobenzimidazoles and benzimidazoles as inhibitors of respiratory syncytial virus replication TIBOTEC PHARMACEUTICALS (IE) 2011-10-25 US disclosed
EP-1697343-B1 AMINOBENZIMIDAZOLES AND BENZIMIDAZOLES AS INHIBITORS OF RESPIRATORY SYNCYTIAL VIRUS REPLICATION TIBOTEC PHARM LTD (IE) 2009-07-01 EP disclosed
US-20070099924-A1 Aminobenzimidazoles and benzimidazoles as inhibitors of respiratory syncytial virus replication JANSSEN SCIENCES IRELAND UC (IE) 2007-05-03 US disclosed
US-20070099924-A1 Aminobenzimidazoles and benzimidazoles as inhibitors of respiratory syncytial virus replication JANSSEN SCIENCES IRELAND UC (IE) 2007-05-03 US disclosed
WO-2005058869-A1 AMINOBENZIMIDAZOLES AND BENZIMIDAZOLES AS INHIBITORS OF RESPIRATORY SYNCYTIAL VIRUS REPLICATION TIBOTEC PHARMACEUTICALS LTD. (IE) 2005-06-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070099924-A1 Aminobenzimidazoles and benzimidazoles as inhibitors of respiratory syncytial virus replication H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, H1-2, H1-4 ALDH1A1 1319/4885KDM4E 704/4885HPGD 2408/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.